Ibi Yutaro, Nishinakamura Ryuichi
Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Eur J Cell Biol. 2024 Dec;103(4):151450. doi: 10.1016/j.ejcb.2024.151450. Epub 2024 Aug 8.
Over the past decade, the induction protocols for the two types of kidney organoids (nephron organoids and ureteric bud organoids) from pluripotent stem cells (PSCs) have been established based on the knowledge gained in developmental nephrology. Kidney organoids are now used for disease modeling and drug screening, but they also have potential as tools for clinical transplantation therapy. One of the options to achieve this goal would be to assemble multiple renal progenitor cells (nephron progenitor, ureteric bud, stromal progenitor) to reproduce the organotypic kidney structure from PSCs. At least from mouse PSCs, all the three progenitors have been induced and assembled into such "higher order" kidney organoids. We will provide an overview of the developmental nephrology required for the induction of renal progenitors and discuss recent advances and remaining challenges of kidney organoids for clinical transplantation therapy.
在过去十年中,基于发育肾脏病学所获得的知识,已经建立了从多能干细胞(PSC)诱导生成两种类型肾类器官(肾单位类器官和输尿管芽类器官)的方案。肾类器官目前用于疾病建模和药物筛选,但它们也有作为临床移植治疗工具的潜力。实现这一目标的选择之一是组装多个肾祖细胞(肾单位祖细胞、输尿管芽、基质祖细胞),以从PSC中重现器官型肾脏结构。至少从小鼠PSC中,已经诱导出了所有这三种祖细胞,并将它们组装成了这种“高阶”肾类器官。我们将概述诱导肾祖细胞所需的发育肾脏病学,并讨论肾类器官在临床移植治疗方面的最新进展和尚存的挑战。